event
PhD Defense bt Vitor Kamada
Primary tabs
Ph.D. Dissertation Defense
Vitor Kamada
Title: Innovation in the Biopharmaceutical Industry
Abstract:
Three aspects of the drug development process are little understood in the literature: 1) which type of organization has comparative advantage in conducting clinical trials, firms or nonprofit organization (NPOs)?; 2) what determines the timing of technological collaboration, a step usually far away from drug commercialization?; and 3) how the strategies making, allying, and buying R&D impact the probability of drug approval? Using data on over 20,000 clinical trials, 800 technological alliances, and 14,000 R&D projects, the main findings of this econometric study are: 1) firms complete each phase of clinical trial faster than nonprofit organizations; 2) licensor scientific and technological specialization is the main factor to speed up the technological collaboration; and 3) R&D projects developed by research alliance have higher probability of drug approval than internal R&D projects, but R&D projects originated from M&A have lower probability of drug approval than internal R&D projects. Together these findings inform policy makers and managers on how to foster the innovation performance in the biopharmaceutical industry.
Committee:
Dr. Usha Nair-Reichert, Chair, Advisor, School of Economics -Georgia Institute of Technology
Dr. Levent Kutlu, School of Economics -Georgia Institute of Technology / Antalya International University
Dr. Patrick S. McCarthy, School of Economics -Georgia Institute of Technology
Dr. Mikhail Klimenko, School of Economics -Georgia Institute of Technology
Dr. Richard Barke, School of Public Policy -Georgia Institute of Technology
Date/Time:
Wednesday, April 26, 2017, 2:00 to 3:30 pm.
Location:
Old CE Building, Room 204.
Groups
Status
- Workflow Status:Published
- Created By:Tatianna Richardson
- Created:04/07/2017
- Modified By:Tatianna Richardson
- Modified:04/07/2017
Categories
Keywords
Target Audience